Tag: oncology
CIRSE launch immuno-oncology trial alongside Immunophotonics
Immunophotonics has announced a collaboration with The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) around a phase 2/3 clinical trial.
The trial is designed...
HistoSonics launches first histotripsy programmes in Hong Kong
HistoSonics has announced the company’s initial partnership in Asia with Hong Kong University receiving their first histotripsy system following a donation from the Li...
“We started off with chinagraphs”: The evolution of radiation oncology
Liz Kenny of the Royal Brisbane and Women’s Hospital (Brisbane, Australia) gave her radiation oncologist’s take on the “120-odd-year” history of radiation therapy, how...
Bariatric embolization: What we know so far
Obesity has been steadily increasing worldwide for at least 50 years. It directly contributes to the rising incidence of cardiovascular, musculoskeletal, and oncological diseases....
Multidisciplinary approach to MSK cancer treatment needs “gaps” filling
Dimitrios Filippiadis (National and Kapodistrian University of Athens , Athens, Greece) was the final speaker to take to the podium at the European Conference...
IO beyond interventional oncology: Progress in immuno-oncology
Recent advances in immuno-oncology are transforming the practice of medical oncology. Currently, antibodies directed against negative regulators of T-cell function, the so-called checkpoint inhibitors,...
Cement and screws: The importance of building (and formalising) evidence on...
At the Society of Interventional Oncology (SIO) annual scientific meeting (19–23 January, Washington DC, USA), Sean Tutton (University of California San Diego Health, San...
Dimitrios Filippiadis
“The spine is an area where interventional radiologists play a crucial role in both diagnosis and therapeutic management of a variety of pathologies”.
Dimitrios...
Boston Scientific announces acquisition of Obsidio
Boston Scientific has announced the acquisition of Obsidio, a privately held company that has developed the Gel Embolic Material (GEM) technology used for embolization...
Shifting paradigms in diagnosing and treating small renal masses
In light of recent and upcoming developments in the space, Vinson Wai-Shun Chan and Tze Min Wah (Leeds, UK) explore the evidence and latest...
Innovative embolic device shows promise for interventional oncology drug delivery
Fluidx Medical’s GPX embolic device has released initial results for Oncology Drug Delivery. Fluidx Medical Technology announced that a next-generation, doxorubicin-loaded GPX embolic device...
Wesley Medical Imaging becomes first hospital in Australia to achieve IASIOS...
Ten centres have achieved the International Accreditation System for Interventional Oncology Services (IASIOS) accreditation, a benchmark of quality standard and assurance, since 2018. Wesley...
Argon Medical Devices announces launch of minimally invasive drainage catheter
Argon Medical Devices has announced the commercial launch of Skater mini-loop drainage catheters in the USA and the European Union.
The Skater mini-loop is a...
Abstract submissions now open for SIO2022
Abstract submissions are now open for next year’s Society of Interventional Oncology annual meeting (SIO2022), which takes place from 3—7 February in San Francisco,...
Italian oncologists urge greater COVID-19 testing amongst healthcare workers treating cancer...
Medical oncologists Filippo Pietrantonio and Marina Chiara (both Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) have launched a social media campaign called #knowyourstatus...
New augmented reality system lets IRs “literally see through the patient”
European Radiology Experimental has recently published a study on a new augmented reality system that is able to accurately guide interventional oncology procedures. A three-step...
Stephen B Solomon
Stephen B Solomon, chief, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, USA and president of the Society for Interventional Oncology (SIO)...
ECR 2018: Will immunotherapy revolutionise cancer care?
Evasion of the immune system is an important mechanism in the development and progression of cancers. Cancer immunotherapies are a promising class of therapeutic...
Artificial intelligence and big data in medical imaging will dramatically change...
The analysis of big data with artificial intelligence (AI) techniques will have an enormous impact on disease prevention, cure and care. By 2030, it...
OsteoCool RF ablation system gets expanded indication for palliative treatment of...
Medtronic has announced that the US FDA has cleared an expanded indication for the OsteoCool radiofrequency (RF) ablation system.
Originally cleared for use in the...
